ID

36504

Description

Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS; ODM derived from: https://clinicaltrials.gov/show/NCT02419638

Link

https://clinicaltrials.gov/show/NCT02419638

Keywords

Versions (2)
  1. 5/17/19 5/17/19 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

May 17, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Sclerosis NCT02419638

English

Eligibility Multiple Sclerosis NCT02419638

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male and female subjects aged 18-65 years old, inclusive.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. a diagnosis of ms as defined by the mcdonald 2010 criteria for ms.
Description

Multiple Sclerosis

Data type

boolean

Alias
UMLS CUI [1]
C0026769
3. relapsing form of ms, defined as at least one relapse in the prior 5 years.
Description

Multiple sclerosis relapse | Relapse Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0856120
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C1265611
4. expanded disability status scale (edss) score of 0 to 5.5, inclusive.
Description

EDSS

Data type

boolean

Alias
UMLS CUI [1]
C0451246
5. english language skills adequate for the completion of questionnaires and cognitive measures.
Description

Language skills English | Questionnaires Completion | Tests Cognitive Completion

Data type

boolean

Alias
UMLS CUI [1,1]
C1145677
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0034394
UMLS CUI [2,2]
C0205197
UMLS CUI [3,1]
C0392366
UMLS CUI [3,2]
C1516691
UMLS CUI [3,3]
C0205197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. subjects with progressive ms.
Description

Progressive multiple sclerosis

Data type

boolean

Alias
UMLS CUI [1]
C1095979
2. subjects with a contraindications for standard treatment with rebif or tecfidera including gi disease, needle phobia, liver disease.
Description

Medical contraindication Rebif | Medical contraindication Tecfidera | Gastrointestinal Disease | Needle phobia | Liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0752980
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C3556178
UMLS CUI [3]
C0017178
UMLS CUI [4]
C0338906
UMLS CUI [5]
C0023895
3. subjects treated with:
Description

Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0087111
high dose intravenous immunoglobulin within 2 months prior to study entry
Description

Intravenous Immunoglobulins High dose

Data type

boolean

Alias
UMLS CUI [1,1]
C0085297
UMLS CUI [1,2]
C0444956
natalizumab within 3 months prior to study entry
Description

natalizumab

Data type

boolean

Alias
UMLS CUI [1]
C1172734
immunosuppressive/immunomodulatory medications including cyclophosphamide, mitoxantrone, azathioprine, methotrexate, rituximab, ofatumumab, ocrelizumab, or alemtuzumab at any time.
Description

Immunosuppressive Agents | Biological Response Modifiers | Cyclophosphamide | Mitoxantrone | Azathioprine | Methotrexate | rituximab | ofatumumab | ocrelizumab | alemtuzumab

Data type

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2]
C0005525
UMLS CUI [3]
C0010583
UMLS CUI [4]
C0026259
UMLS CUI [5]
C0004482
UMLS CUI [6]
C0025677
UMLS CUI [7]
C0393022
UMLS CUI [8]
C1832027
UMLS CUI [9]
C1882138
UMLS CUI [10]
C0383429
4. subjects with absolute lymphocyte count < 800 cells (mm3).
Description

Absolute lymphocyte count

Data type

boolean

Alias
UMLS CUI [1]
C3544087
5. subjects with any of the following neurologic/psychiatric disorder:
Description

Nervous system disorder | Mental disorders

Data type

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0004936
severe depression during the past 12 months before screening;
Description

Severe depression

Data type

boolean

Alias
UMLS CUI [1]
C0588008
history of substance abuse (treatment or alcohol) or any other factor (i.e., serious psychiatric condition) that may interfere with the subject's ability to cooperate and comply with the study procedures;
Description

Substance Use Disorders | Factor Interferes with Compliance behavior | Mental condition Serious Interferes with Compliance behavior | Factor Interferes with Protocol Compliance | Mental condition Serious Interferes with Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2,1]
C1521761
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C1321605
UMLS CUI [3,1]
C3840291
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0521102
UMLS CUI [3,4]
C1321605
UMLS CUI [4,1]
C1521761
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0525058
UMLS CUI [5,1]
C3840291
UMLS CUI [5,2]
C0205404
UMLS CUI [5,3]
C0521102
UMLS CUI [5,4]
C0525058
6. subjects unable to undergo mri scans, including claustrophobia or history of hypersensitivity to gadolinium-dtpa.
Description

MRI scan Receive Unable | Claustrophobia | Hypersensitivity Gadolinium DTPA

Data type

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
UMLS CUI [2]
C0008909
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0060933
7. pregnant or nursing females, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hcg laboratory test.
Description

Pregnancy | HCG pregnancy test Positive | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0546577
UMLS CUI [2,2]
C1514241
UMLS CUI [3]
C0006147
8. female subjects of childbearing potential, defined as all females physiologically capable of becoming pregnant, unless they agree to abstinence or, if sexually active, the use of contraception.
Description

Childbearing Potential | Childbearing Potential Sexual Abstinence | Childbearing Potential Sexually active Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0036899
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0241028
UMLS CUI [3,3]
C0700589
9. history of hypersensitivity to any of the study treatments or to treatments of similar chemical classes.
Description

Hypersensitivity Investigational Therapy | Hypersensitivity Therapy Similar

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0949266
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C2348205
10. subjects with abnormal liver function test (lft) levels
Description

Liver function tests abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0151766
Back to the top of the page

Similar models

Eligibility Multiple Sclerosis NCT02419638

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. male and female subjects aged 18-65 years old, inclusive.
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis
Item
2. a diagnosis of ms as defined by the mcdonald 2010 criteria for ms.
boolean
C0026769 (UMLS CUI [1])
Multiple sclerosis relapse | Relapse Quantity
Item
3. relapsing form of ms, defined as at least one relapse in the prior 5 years.
boolean
C0856120 (UMLS CUI [1])
C0035020 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
EDSS
Item
4. expanded disability status scale (edss) score of 0 to 5.5, inclusive.
boolean
C0451246 (UMLS CUI [1])
Language skills English | Questionnaires Completion | Tests Cognitive Completion
Item
5. english language skills adequate for the completion of questionnaires and cognitive measures.
boolean
C1145677 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0034394 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0392366 (UMLS CUI [3,1])
C1516691 (UMLS CUI [3,2])
C0205197 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Progressive multiple sclerosis
Item
1. subjects with progressive ms.
boolean
C1095979 (UMLS CUI [1])
Medical contraindication Rebif | Medical contraindication Tecfidera | Gastrointestinal Disease | Needle phobia | Liver disease
Item
2. subjects with a contraindications for standard treatment with rebif or tecfidera including gi disease, needle phobia, liver disease.
boolean
C1301624 (UMLS CUI [1,1])
C0752980 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C3556178 (UMLS CUI [2,2])
C0017178 (UMLS CUI [3])
C0338906 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
Therapeutic procedure
Item
3. subjects treated with:
boolean
C0087111 (UMLS CUI [1])
Intravenous Immunoglobulins High dose
Item
high dose intravenous immunoglobulin within 2 months prior to study entry
boolean
C0085297 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
natalizumab
Item
natalizumab within 3 months prior to study entry
boolean
C1172734 (UMLS CUI [1])
Immunosuppressive Agents | Biological Response Modifiers | Cyclophosphamide | Mitoxantrone | Azathioprine | Methotrexate | rituximab | ofatumumab | ocrelizumab | alemtuzumab
Item
immunosuppressive/immunomodulatory medications including cyclophosphamide, mitoxantrone, azathioprine, methotrexate, rituximab, ofatumumab, ocrelizumab, or alemtuzumab at any time.
boolean
C0021081 (UMLS CUI [1])
C0005525 (UMLS CUI [2])
C0010583 (UMLS CUI [3])
C0026259 (UMLS CUI [4])
C0004482 (UMLS CUI [5])
C0025677 (UMLS CUI [6])
C0393022 (UMLS CUI [7])
C1832027 (UMLS CUI [8])
C1882138 (UMLS CUI [9])
C0383429 (UMLS CUI [10])
Absolute lymphocyte count
Item
4. subjects with absolute lymphocyte count < 800 cells (mm3).
boolean
C3544087 (UMLS CUI [1])
Nervous system disorder | Mental disorders
Item
5. subjects with any of the following neurologic/psychiatric disorder:
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
Severe depression
Item
severe depression during the past 12 months before screening;
boolean
C0588008 (UMLS CUI [1])
Substance Use Disorders | Factor Interferes with Compliance behavior | Mental condition Serious Interferes with Compliance behavior | Factor Interferes with Protocol Compliance | Mental condition Serious Interferes with Protocol Compliance
Item
history of substance abuse (treatment or alcohol) or any other factor (i.e., serious psychiatric condition) that may interfere with the subject's ability to cooperate and comply with the study procedures;
boolean
C0038586 (UMLS CUI [1])
C1521761 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C1321605 (UMLS CUI [2,3])
C3840291 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C1321605 (UMLS CUI [3,4])
C1521761 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0525058 (UMLS CUI [4,3])
C3840291 (UMLS CUI [5,1])
C0205404 (UMLS CUI [5,2])
C0521102 (UMLS CUI [5,3])
C0525058 (UMLS CUI [5,4])
MRI scan Receive Unable | Claustrophobia | Hypersensitivity Gadolinium DTPA
Item
6. subjects unable to undergo mri scans, including claustrophobia or history of hypersensitivity to gadolinium-dtpa.
boolean
C0024485 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0008909 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0060933 (UMLS CUI [3,2])
Pregnancy | HCG pregnancy test Positive | Breast Feeding
Item
7. pregnant or nursing females, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hcg laboratory test.
boolean
C0032961 (UMLS CUI [1])
C0546577 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3])
Childbearing Potential | Childbearing Potential Sexual Abstinence | Childbearing Potential Sexually active Contraceptive methods
Item
8. female subjects of childbearing potential, defined as all females physiologically capable of becoming pregnant, unless they agree to abstinence or, if sexually active, the use of contraception.
boolean
C3831118 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0036899 (UMLS CUI [2,2])
C3831118 (UMLS CUI [3,1])
C0241028 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
Hypersensitivity Investigational Therapy | Hypersensitivity Therapy Similar
Item
9. history of hypersensitivity to any of the study treatments or to treatments of similar chemical classes.
boolean
C0020517 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
Liver function tests abnormal
Item
10. subjects with abnormal liver function test (lft) levels
boolean
C0151766 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial